Lui, David Tak Wai http://orcid.org/0000-0002-9813-1126
Tang, Eric Ho Man http://orcid.org/0000-0003-4196-8686
Wu, Tingting http://orcid.org/0000-0003-3609-5016
Au, Ivan Chi Ho http://orcid.org/0000-0001-5904-8322
Lee, Chi Ho http://orcid.org/0000-0002-7569-409X
Woo, Yu Cho
Tan, Kathryn Choon Beng http://orcid.org/0000-0001-9037-0416
Wong, Carlos King Ho http://orcid.org/0000-0002-6895-6071
Article History
Received: 5 January 2023
Accepted: 14 February 2023
First Online: 24 February 2023
Declarations
:
: The study protocol was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (Reference number: UW 21-320). Informed consent from patients was not required for the use of de-identified data for this cohort analysis.
: Not applicable.
: CKHW reports receipt of research funding from the EuroQoL Group Research Foundation, AstraZeneca, and Boehringer Ingelheim, unrelated to this work. All other authors declare no competing interests.